A drug that could potentially extend the life of large-breed dogs is closer to being approved by the U.S. Food and Drug Administration (FDA). That’s according to an announcement last week by the San Francisco biotech company Loyal, the company behind the drug. Currently, there are no FDA-approved or conditionally …
Read More »